Company

Management Management

  • Management
  • Scientific Advisory Board
Samyang  has built a team of innovative and successful drug developers whose deep collective experience spans drug discovery, research, and development at leading biotechnology and pharmaceutical companies Samyang  has built a team of innovative and successful drug developers whose deep collective experience spans drug discovery, research, and development at leading biotechnology and pharmaceutical companies
President Eom, Tae-Woong Profile Image
Tae-Ung Eom
President

After graduating with a degree in chemistry from Sogang University, the President, Tae-Ung Eom, worked in the strategic planning field for 35 years as part of the Samyang Group and led a number of major M&A and C&D as a strategic planning specialist within Samyang Group. Since 2015, he has been serving as the President of Samyang Biopharmaceuticals Corp., Inc. and is proceeding with the plan to create and implement a new 2020 vision.

Chief Stategy Officer의 Helen  Lee Profile Image.
Hyun-Jung Helen Lee
M.D., Chief Strategy Officer and Chief Medical Officer

Hyun-Jung Helen Lee, M.D., Chief Strategy Officer and Chief Medical Officer Hyun-Jung Helen Lee, M.D. is a gynecologist by training and has been working on the development of anti-cancer drugs for 15 years in Global, the US and the Asia. Prior to joining Samyang Biopharmaceuticals Corp., she served as the Global Head of Solid Tumor Clinical Development at Shire in the US. She has held various executive positions at Baxalta / Baxter and Eli Lilly in the US and also worked as a product physician at Pfizer Korea. After graduating from Yonsei University College of Medicine, she completed her residency training at Severance Hospital, and later, earned her master's degree in Health Care Management at Harvard School of Public Health. Currently, she is in charge of establishing strategies of corporate and R&D as Chief Strategy Officer and leading clinical development as Chief Medical Officer at Samyang Biopharmaceuticals Corp..

Biopharmaceutical Research Director Min-hyo Seo Profile Image.
Min-Hyo Seo
Vice President / R&D Center

Min-Hyo Seo, received his Ph.D. in chemistry from Seoul National University and joined Samyang in 1991. Later, he studied in CCCD at the pharmacology school of University of Utah in 1996 and subsequently returned to Korea to work on Genexol® PM, which is an incrementally modified anticancer drug, as well as on the R&D of the polymer drug delivery system. Recognized for his prestigious achievements in R&D, he was listed in the 2008 edition of ‘Marquez Hughes in the World’, one of the world's three major biographical dictionaries. Currently serving as the head of Samyang Biopharmaceuticals R&D Center, he is directing the development of cutting-edge technologies, such as siRNA, anticancer immunotherapy, that can undoubtedly lead the way globally as well as shape future trends. Also, he is in charge of developing biodegradable polymer applications and wound sealing products in the MD field as well securing new platform technology in the R&D.

Chief Biopharmaceutical Officer Yong-jin Lee Profile Image.
Yong-Jin Lee
Vice President / Pharmaceutical Business

Yong-Jin Lee received his Bachelor’s degree in Biology at Korea University, and his MBA at Dongguk University. Since 2001, he has joined Samyang and led Regulatory Affairs and Oncology Sales teams. He is now directing the pharmaceutical business at Samyang Biopharmaceuticals Corp. He was recognized and awarded by the Minister of Ministry of Food and Drug Safety and Minister of Ministry of Health and Welfare. Specialized in sales and marketing, Mr. Lee will not direct both domestic and overseas pharmaceutical business of Samyang.

Chief MD Officer Jae–Doo Lee Profile Image.
Jae-Do Lee
Vice President / MD Business

Jae-Do Lee, received his Bachelor's and Master's degree in chemical engineering from Hanyang University. He joined Samyang in 1993 and is currently working in the field of medical devices. After the release of the medical suture product in 1996, he was in charge of the overseas sales of the medical suture, and contributed greatly to establishing the company's global business base for the suture. Currently, he is directing sales, marketing and the MD plant in the medical device division.

  • Robert P. Pinkas Family Professor of Bioengineering, School of Engineering and Applied Sciences, Harvard University
  • Core Member, Wyss Institute for Biologically Inspired Engineering at Harvard University
  • Adjunct Investigator, Diabetes Endocrinology Research Center, Joslin Diabetes Center
  • Director of the Biologic Therapeutics Center and Distinguished Professor of Radiation Oncology, Washington University School of Medicine
  • Director of the Gene Therapy Center and the Division of Human Gene Therapy, University of Alabama at Birmingham
  • Asso. Director for Education & Training, City of hope Comprehensive Cancer Center
  • Chair/Prof., Dept. of Molecular & Cellular Biology, Beckman Research Institute of City of Hope
  • Dean, Irell and Manella Graduate School of Biological Sciences, City of Hope.
  • Principal Research Scientist, Center for Theragnosis, Biomedical Research Institute, KIST
  • Professor of Medical Oncology Department of Internal Medicine, SNU & SNUH
  • Assistant Professor, Associate Professor, Graduate School of Medical Science and Engineering, KAIST, Daejeon, Korea
  • KAIST Endowed Chair Professor, Graduate School of Medical Science and Engineering, KAIST, Daejeon, Korea
  • Chair, Academic Committee, The Korean Vaccine Society, Korea
  • Member, Immunology working group, International Coalition to Eliminate Hepatitis B Virus (ICE-HBV)
  • Professor, Dept. of Advanced Materials & Chemical Engineering, Hannam University, Korea
  • Director, BrainKorea21Plus Center for BT-IT Hybrid Nanomaterials, Hannam University, Korea
  • D. Mooney
    D. Mooney
  • D. Curiel
    D. Curiel
  • Robert P. Pinkas Family Professor of Bioengineering, School of Engineering and Applied Sciences, Harvard University
  • Core Member, Wyss Institute for Biologically Inspired Engineering at Harvard University
  • Adjunct Investigator, Diabetes Endocrinology Research Center, Joslin Diabetes Center
  • Director of the Biologic Therapeutics Center and Distinguished Professor of Radiation Oncology, Washington University School of Medicine
  • Director of the Gene Therapy Center and the Division of Human Gene Therapy, University of Alabama at Birmingham
  • J. Rossi
    J. Rossi
  • Ick Chan Kwon
    Ick Chan Kwon
  • Asso. Director for Education & Training, City of hope Comprehensive Cancer Center
  • Chair/Prof., Dept. of Molecular & Cellular Biology, Beckman Research Institute of City of Hope
  • Dean, Irell and Manella Graduate School of Biological Sciences, City of Hope.
  • Principal Research Scientist, Center for Theragnosis, Biomedical Research Institute, KIST
  • Yung-Jue Bang
    Yung-Jue Bang
  • Eui-Cheol Shin
    Eui-Cheol Shin
  • Professor of Medical Oncology Department of Internal Medicine, SNU & SNUH
  • Assistant Professor, Associate Professor, Graduate School of Medical Science and Engineering, KAIST, Daejeon, Korea
  • KAIST Endowed Chair Professor, Graduate School of Medical Science and Engineering, KAIST, Daejeon, Korea
  • Chair, Academic Committee, The Korean Vaccine Society, Korea
  • Member, Immunology working group, International Coalition to Eliminate Hepatitis B Virus (ICE-HBV)
  • Jin-Ho Lee
    Jin-Ho Lee
  • Professor, Dept. of Advanced Materials & Chemical Engineering, Hannam University, Korea
  • Director, BrainKorea21Plus Center for BT-IT Hybrid Nanomaterials, Hannam University, Korea